BIONICAL LIMITED
Get an alert when BIONICAL LIMITED files next
Leroy will email you the moment a new filing lands at Companies House — one short note per filing, nothing else.
Cash
£1.1m
-67.3% lowest in 3 filed years
Net assets
-£11m
-12.5% lowest in 3 filed years
Employees
165
-27.6% lowest in 3 filed years
Profit before tax
£306k
+108.9% highest in 3 filed years
Watchouts
Facts from the Companies House register and the latest accounts — not a rating
-
Negative shareholders' funds
Net assets
3-year trend · vs Consumer Discretionary median
Accounts
3-year trend · Δ = latest vs prior filed period · latest reflected 2025-12-31
| Metric | Trend | 2023-12-31 | 2024-12-31 | 2025-12-31 | Δ vs prior |
|---|---|---|---|---|---|
| Turnover | £82,752,000 | £53,413,000 | £55,109,000 | +3.2% | |
| Operating profit | £922,000 | -£3,979,000 | £2,663,000 | +166.9% | |
| Profit before tax | -£860,000 | -£3,453,000 | £306,000 | +108.9% | |
| Net profit | -£932,000 | -£3,512,000 | £208,000 | +105.9% | |
| Cash | £1,889,000 | £3,383,000 | £1,105,000 | -67.3% | |
| Total assets less current liabilities | £3,472,000 | £4,106,000 | £6,439,000 | +56.8% | |
| Net assets | -£5,980,000 | -£9,346,000 | -£10,513,000 | -12.5% | |
| Equity | -£5,980,000 | -£9,346,000 | -£10,513,000 | -12.5% | |
| Average employees | 222 | 228 | 165 | -27.6% | |
| Wages | £15,835,000 | £13,963,000 | £10,697,000 | -23.4% | |
| Directors' remuneration | £1,051,000 | £1,122,000 | £454,000 | -59.5% | |
| Directors' pension contributions | £9,000 | £21,000 | £21,000 | 0% | |
| Highest paid director | £534,000 | £651,000 | £554,000 | -14.9% |
Values shown as filed in the company's annual accounts. — indicates the figure wasn't present under that line item in that period. The Δ column is the change from the prior filed period as a percentage of |prior|; lines a company doesn't report show —. About these numbers
Ratios
Computed from the line items above — sparklines read oldest → newest
| Ratio | Trend | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|---|
| Operating margin | 1.1% | -7.4% | 4.8% | |
| Net margin | -1.1% | -6.6% | 0.4% | |
| Return on capital employed | 26.6% | -96.9% | 41.4% | |
| Gearing (liabilities / total assets) | 133.9% | 156.7% | 164.0% | |
| Current ratio | — | 1.11x | 1.37x | |
| Interest cover | 0.51x | -1.77x | 1.13x |
Margins divide P&L lines by turnover. Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.
Name history
Renamed 2 times since incorporation
- BIONICAL LIMITED 2014-11-07 → present
- ELLIS PHARMA LIMITED 2009-11-12 → 2014-11-07
- ELLIOTT PHARMA LIMITED 2009-10-28 → 2009-11-12
Audit & accounting basis
- Accounting basis
- FRS 102
- Reporting scope
- Consolidated group
- Auditor
- RSM UK Audit LLP
- Audit opinion
- Unqualified (clean)
- Going concern
- Affirmed
“The financial statements have been prepared on the going concern basis which the directors believe to be appropriate for the following reasons. The directors have prepared cash flow forecasts for a 12 month period from the date of approval of these financial statements and such forecasts have indicated that sufficient funds should be available to enable the group and company to continue in operational existence for the foreseeable future by meeting its liabilities and contingent liabilities as they fall due for payment.”
Group structure
- BIONICAL LIMITED · parent
- Bionical EMAS Inc. 100%
- Bionical EMAS GmbH 100%
- Bionical EMAS Limited 100%
- EMAS Pharma SA 100%
- Bionical CTS Limited 100%
- Bionical CTS, Inc 100%
Significant events
- “Following the disposal of the Clinical Development division in December 2024, the group has benefited from a more focused operational structure.”
Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers
People
3 active · 9 resigned
| Name | Role | Appointed | Born | Nationality |
|---|---|---|---|---|
| BORKOWSKI, Andrew Thomas | Director | 2016-01-01 | Jun 1962 | British |
| LEAVER, Andrew Derrick | Director | 2009-10-28 | Dec 1962 | British |
| WATSON, Tom | Director | 2022-03-01 | Sep 1977 | British |
Show 9 resigned officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| HOLLINGWORTH, Angela Helen | Secretary | 2011-07-31 | 2012-04-24 |
| THOMAS, Lucy Kate | Secretary | 2012-04-24 | 2015-12-08 |
| WOOD, Robert Macgregor Warburton | Secretary | 2009-10-28 | 2011-07-31 |
| BRACEY, Jonathan Edward | Director | 2013-09-01 | 2014-06-27 |
| CAMPBELL, Gary | Director | 2012-04-24 | 2013-10-31 |
| LEAVER, Darren | Director | 2019-01-10 | 2022-03-01 |
| LEAVER, Linda | Director | 2009-10-28 | 2012-12-31 |
| MCINTOSH, Graham | Director | 2014-01-06 | 2018-07-12 |
| WARING-HUGHES, Jonathan | Director | 2019-01-10 | 2022-08-01 |
Ownership
Persons with significant control
| Name | Kind | Nature of control | Notified | Status |
|---|---|---|---|---|
| Mr Andrew Derrick Leaver | Individual | Shares 75–100%, Voting 75–100%, Appoints directors | 2016-04-06 | Active |
Filing timeline
Last 20 of 97 total filings
Material constitutional events — rename, articles re-file, resolution
- 2023-06-15 RESOLUTIONS Resolution
- 2023-05-19 MA Memorandum articles
- 2023-05-19 RESOLUTIONS Resolution
| Date | Type | Category | Description | |
|---|---|---|---|---|
| 2026-08-05 | AA | accounts | Accounts with accounts type group | |
| 2026-01-27 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2025-11-21 | RP01PSC01 | miscellaneous | Legacy | |
| 2025-10-06 | AA | accounts | Accounts with accounts type group | |
| 2025-01-17 | CH01 | officers | Change person director company with change date | |
| 2025-01-17 | PSC04 | persons-with-significant-control | Change to a person with significant control | |
| 2024-10-30 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2024-08-09 | AA | accounts | Accounts with accounts type group | |
| 2024-05-02 | CH01 | officers | Change person director company with change date | |
| 2023-12-29 | PSC04 | persons-with-significant-control | Change to a person with significant control | |
| 2023-11-30 | CH01 | officers | Change person director company with change date | |
| 2023-11-13 | CS01 | confirmation-statement | Confirmation statement with updates | |
| 2023-11-11 | AA | accounts | Accounts with accounts type group | |
| 2023-06-15 | RESOLUTIONS | resolution | Resolution | |
| 2023-06-07 | SH01 | capital | Capital allotment shares | |
| 2023-05-19 | SH01 | capital | Capital allotment shares | |
| 2023-05-19 | MA | incorporation | Memorandum articles | |
| 2023-05-19 | RESOLUTIONS | resolution | Resolution | |
| 2023-01-07 | AA | accounts | Accounts with accounts type group | |
| 2022-11-08 | CS01 | confirmation-statement | Confirmation statement with no updates |
Public-record activity
Raw counts from Companies House — last 12–24 months
- Filings
- 4
- Capital events
- 0
- Officers appointed
- 0
- Officers resigned
- 0
last 12 months
last 24 months
last 12 months
last 12 months
Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.